Houston, TX – According to filings with the U.S. Securities and Exchange Commission, Solugen is raising $356,949,936.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Gaurab Chakrabarti played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Solugen
Solugen is a venture-backed biotech startup that produces high-performance chemicals from plant-derived substitutes. Our award-winning hydrogen peroxide technology was developed in-house by a team of doctors, scientists, and engineers from MIT. Solugen is a manufacturer and supplier of registered biocides and specialty bio-based solutions for divalent control in process flow assurance and asset integrity. We challenge the traditional approach to chemicals production, which is capital intensive, dangerous, environmentally unfriendly and largely unchanged since 1942. Our patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with the competition.

To learn more about Solugen, visit http://www.solugentech.com/

Contact:
Gaurab Chakrabarti, Chief Executive Officer
713-380-2134
https://www.linkedin.com/in/gaurabchakrabarti/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved